HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Promises 500 Million OTC COVID-19 Tests As Demand In US Spikes On Omicron Spread

Executive Summary

With demand for home-use COVID-19 tests already nearly out-stripping supply as the Omicron variant rapid spreads coronavirus infections across the US, manufacturers are looking at increasing production as much as possible.

You may also be interested in...



Ordering Starts For Free OTC COVID-19 Tests; USPS Deliveries Expected Within Two Weeks

US consumers can order up to four rapid antigen tests per household through USPS website, or a phone hotline coming soon. Biden administration, which is working to buy another 500m tests soon, notes more OTC tests are becoming available through an accelerated pathway to support FDA reviews of for emergency use authorizations of tests with potential for large-scale manufacturing.

Winter Is Coming For COVID-19 In US: Biden Makes OTC Tests Eligible For Insurance Claims

White House also announced it would double commitment it made in September for number of OTC test kits to be distributed free by community groups from 25m kits to 50m and would add rural clinics to the program.

US FDA Grants Three OTC Covid-19 Test EUAs Following Template Updates To Spur Development

Access Bio’s CareStart COVID-19 Antigen test gives results within 10 minutes, Becton, Dickinson’s BD Veritor within 15 minutes and InBios International’s SCoV-2 Ag Detect within 20 minutes.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel